OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:
|What:||Transgenomic, Inc. First Quarter 2014 Financial Results and Business Update Conference Call|
|When:||Wednesday, May 7, 2014 @ 5:00 p.m. Eastern|
|How:||Live over the Internet -- Simply log on to the web at the address above.|
|Contact:||Investor Relations, 402-452-5416|
To access the call via telephone, dial 866-952-1907 from the U.S. and Canada or 785-424-1826 for international participants and enter conference ID TRANS. A telephone replay will be available from 8:00 p.m. Eastern Time on May 7, 2014 through 11:59 p.m. Eastern Time on May 21, 2014 by dialing 800-839-3020 (domestic) or 402-220-7234 (international).
About Transgenomic, Inc.
Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases. The Company has three complementary business units: Patient Testing, Biomarker Identification, and Genetic Assays and Platforms, which provide specialized diagnostic tests, contract research services for drug development, and equipment, reagents and other consumables for clinical and research applications in molecular testing and cytogenetics.